GLANZMANN THROMBASTHENIA
Clinical trials for GLANZMANN THROMBASTHENIA explained in plain language.
Never miss a new study
Get alerted when new GLANZMANN THROMBASTHENIA trials appear
Sign up with your email to follow new studies for GLANZMANN THROMBASTHENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for controlling dangerous bleeding in rare disorder
Disease control Recruiting nowThis study is testing an investigational drug called eptacog beta to see if it can safely and effectively treat and prevent serious bleeding episodes in people with Glanzmann Thrombasthenia, a rare inherited bleeding disorder. Six participants with a history of severe bleeding wi…
Matched conditions: GLANZMANN THROMBASTHENIA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists seek genetic clues to mysterious bleeding disorders
Knowledge-focused Recruiting nowThis research study aims to better understand inherited blood disorders like Glanzmann thrombasthenia, a condition that causes excessive bleeding. Researchers will analyze blood samples from patients and healthy volunteers to study how blood cells work and identify genetic causes…
Matched conditions: GLANZMANN THROMBASTHENIA
Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC